EBV-specific T cells are enriched following Autologous Stem Cell Transplant for MS

被引:0
|
作者
Massey, Jennifer [1 ]
Artuz, Crisbel [1 ]
Dyer, Zoe [2 ]
Jackson, Katherine [3 ]
Khoo, Melissa [1 ]
Moore, John [1 ]
Ma, David [1 ]
Sutton, Ian [1 ]
机构
[1] St Vincents Hosp, Sydney, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Garvan Inst Med Res, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O057/1523
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [31] GENERATION OF EBV-SPECIFIC AND EBV-SPECIFIC, TCR-REPROGRAMMED HUMAN CD8+CYTOTOXIC T LYMPHOCYTES WITH STEM CELL MEMORY AND CENTRAL MEMORY PROPERTIES BY MODULATING GLYCOLYTIC T CELL METABOLISM
    Weber, I.
    Khan, S.
    Theobald, M.
    Hartwig, U. F.
    HAEMATOLOGICA, 2015, 100 : 171 - 171
  • [32] Quantitative analysis of EBV-specific T cells in retrovirally transduced donor leukocytes after stimulation with mitogens or autologous EBV-BLCL.
    Koehne, G
    Gallardo, HF
    Sadelain, M
    O'Reilly, RJ
    BLOOD, 1999, 94 (10) : 418B - 418B
  • [33] AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT IN MS
    Joyutpal, Das
    John, Snowden
    Sona, Mistry
    Simon, Bell
    Helen, Jessop
    Basil, Sharrack
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [34] Chronic Active Epstein-Barr Virus Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-specific T Cells
    Meedt, Elisabeth
    Weber, Daniela
    Bonifacius, Agnes
    Eiz-Vesper, Britta
    Maecker-Kolhoff, Britta
    Delecluse, Susanne
    Delecluse, Henri-Jacques
    Lorenz, Myriam
    Schwarz, Klaus
    Meedt, Stefan T.
    Braess, Jan
    Herr, Wolfgang
    Holler, Ernst
    Edinger, Matthias
    Wolff, Daniel
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (12) : 2200 - 2202
  • [35] EBV-specific T-cell immunity: relevance for multiple sclerosis
    Behrens, Malina
    Comabella, Manuel
    Luenemann, Jan D.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Autologous EBV-specific cytotoxic T lymphocyte (CTL) infusions as early intervention for liver transplant recipients with lymphoproliferative disease.
    Savoldo, B
    Huls, HM
    Lopez, T
    Caldwell, YL
    Finegold, MJ
    Goss, J
    Karpen, SJ
    Gee, A
    Brenner, MK
    Rooney, CM
    Heslop, HE
    BLOOD, 2002, 100 (11) : 363A - 364A
  • [37] Serum Biomarkers Following Autologous Haematopoetic Stem Cell Transplant for Aggressive MS
    Thebault, Simon
    Tessier, Daniel
    Bowman, Marjorie
    Lee, Hyunwoo
    Arnold, Douglas L.
    Tabard-Cossa, Vincent
    Freedman, Mark S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 29 - 29
  • [38] Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
    Lee, SP
    SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) : 463 - 471
  • [39] Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-Specific T cells
    Comoli, P
    Maccario, R
    Locatelli, F
    Valente, U
    Basso, S
    Garaventa, A
    Tomà, P
    Botti, G
    Melioli, G
    Baldanti, F
    Nocera, A
    Perfumo, F
    Ginevri, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) : 1415 - 1422
  • [40] EBV-specific T cell immunity in pediatric post-transplant lymphoproliferative disease after organ transplantation
    Wilsdorf, N.
    Eiz-Vesper, B.
    Henke-Gendo, C.
    Klein, C.
    Maecker-Kolhoff, B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 28 - 29